Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells

Cancer Chemotherapy and Pharmacology
Baoli QinShuji Nakano

Abstract

Although gefitinib, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, has been demonstrated to exhibit its antitumor activity by the blockade of EGF receptor, the role of signaling pathways downstream of EGFR in gefitinib sensitivity remains unknown. In this study, we investigated the mechanistic role of Src and Ras, major oncogene products implicated in the pathogenesis of many human cancers in gefitinib sensitivity. Using parental and v-src- or c-H-ras-transfected HAG-1 human gallbladder adenocarcinoma cell lines, effects of gefitinib on cytotoxicity, cell cycle purtubation and apoptosis, and tyrosine phosphorylation of EGFR, Akt, and Erk were determined by WST-1 assay, flow cytometry, and Western blots, respectively. Activated Ras and Src conferred a strong resistance to gefitinib by nearly 30-fold and 200-fold, respectively. Gefitinib induced accumulation of cells in the G0/G1 phase of the cell cycle at 24-h, with progressive expansion of apoptotic cell population in parental HAG-1 cells, but these effects were completely abolished in v-src- or c-H-ras-transfected cell line. Upon gefitinib treatment, EGFR activation and subsequent downstream activation through Erk and Akt were significantly i...Continue Reading

References

Jan 1, 1987·Annual Review of Cell Biology·R Jove, H Hanafusa
Oct 24, 1995·Biochemical and Biophysical Research Communications·K SatoY Fukami
Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Apr 10, 1995·International Journal of Cancer. Journal International Du Cancer·T TatsumotoY Niho
Nov 1, 1994·In Vitro Cellular & Developmental Biology. Animal·S NakanoY Niho
Sep 1, 1994·Human Pathology·S Valerdiz-Casasola
Apr 1, 1996·Current Opinion in Cell Biology·R Treisman
Jun 13, 1998·Journal of the National Cancer Institute·J Rubin GrandisD J Tweardy
Aug 26, 1998·Molecular and Cellular Biology·M A OlayioyeN E Hynes
Sep 3, 1998·The Journal of Biological Chemistry·J YanJ F Hancock
Nov 1, 2000·Cell·J Schlessinger
Dec 15, 2000·Oncogene·R B Irby, T J Yeatman
Mar 20, 2003·Seminars in Oncology·Francis M Sirotnak
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Jul 9, 2005·International Journal of Cancer. Journal International Du Cancer·Maarten L JanmaatGiuseppe Giaccone
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Miguel TaronTeresa Moran

❮ Previous
Next ❯

Citations

Apr 5, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G Giaccone, P A Zucali
May 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P A ZucaliG Giaccone
Mar 14, 2007·Anti-cancer Drugs·Ami N Shah, Gary E Gallick
Apr 9, 2009·Cancer Research·Elizabeth Peterson-RothPeter M Glazer
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicolas GirardWilliam Pao
Nov 13, 2010·Thoracic Surgery Clinics·Nicolas Girard
Oct 1, 2010·Surgical Oncology·Sanjeev K MauryaHari S Shukla
Feb 2, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Robert L KeithYork E Miller
Aug 22, 2012·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Zhi XiaoLili Tang
Jun 4, 2013·Biochemical and Biophysical Research Communications·Misaki OnoShuji Nakano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis